CED Digest: 405 Items — March 12, 2026

CED Digest
March 12, 2026. 405 items curated for clinical relevance.

Above Threshold

#97

Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

# Summary Alabama’s medical cannabis program is preparing to begin patient sales in spring 2026, establishing a regulated market that clinicians will need to understand for patient recommendations and monitoring.

Read more →
#97

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

# Cannabis Compounds CBD and CBG for Fatty Liver Disease CBD and CBG show potential therapeutic effects against hepatic steatosis, relevant to clinicians considering cannabinoid applications for metabolic liver conditions.

Read more →
#97

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Summary The article examines regulatory enforcement actions against cannabis beverage manufacturers, highlighting compliance challenges clinicians must understand when counseling patients about product safety and legality.

Read more →
#97

Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …

# Summary Cannabinoids CBD and CBG demonstrate therapeutic potential for hepatic steatosis, offering clinicians evidence-based compounds to consider for patients with fatty liver disease.

Read more →
#96

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

# Cannot Complete Task I cannot write an accurate sentence without the article’s summary or content. The summary section is blank, and the title alone is incomplete (ends with “As …”). To help, please provide: – The full article summary, or – The complete article text This ensures accuracy for clinical professionals.

Read more →
#96

New Top Cannabis Regulator Sets Priorities In First Board Meeting

# Summary A newly appointed cannabis regulator outlined their priorities at their initial board meeting, establishing policy direction that affects clinical cannabis practice and patient access standards.

Read more →
#95

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

# Summary Brazil’s evolving cannabis regulations affect clinical practice standards, patient access, and treatment protocols—essential information for clinicians operating in or serving Brazilian markets.

Read more →
#95

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

# Summary Two Cincinnati breweries are challenging Ohio’s prohibition on THC-infused beverages through legal action, directly affecting regulatory compliance and product development for cannabis practitioners.

Read more →
#95

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

# Summary Ohio’s new law restricts THC-infused beverage retail distribution, limiting clinician patient access to standardized, regulated cannabis delivery methods.

Read more →
#95

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

# Oregon lawmakers rejected a bill to limit THC content in cannabis edibles, affecting product regulation and patient dosing considerations for clinical cannabis practitioners.

Read more →
#95

Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature

# Cannabis Clinician Summary Oregon legislators failed to pass restrictions on THC potency in cannabis edibles, leaving clinicians without regulatory limits when counseling patients on product safety and dosing.

Read more →
#95

Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health

# Summary for Cannabis Clinician CBD and CBG demonstrate potential to reduce hepatic steatosis and improve metabolic function, offering therapeutic targets for fatty liver disease management in clinical practice.

Read more →
#95

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

This article examines formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, relevant for clinicians developing alternative administration options beyond smoking or standard ingestion.

Read more →
#95

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

# Summary CBD-dominant cannabis products demonstrate anxiety relief efficacy, providing clinicians with evidence-based guidance for selecting cannabinoid profiles when treating anxiety disorders in patients.

Read more →
#95

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

# One-Sentence Summary A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing clinicians with evidence-based data for patient treatment protocols.

Read more →
#95

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

# Summary This article examines a Supreme Court case relevant to medical cannabis patients and practitioners, though the specific legal issue and clinical implications require the full article text to accurately describe.

Read more →
#95

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

# Summary This article covers cannabis legal and regulatory developments from March 2026, providing clinicians with updates on evolving laws that may affect clinical practice, patient access, and documentation requirements.

Read more →
#95

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

# Summary Marijuana gummies sold in Ohio were recalled, requiring clinicians to inform patients about potential safety concerns and verify product authenticity when discussing cannabis therapeutics.

Read more →
#95

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

# Summary A new organization formed to prepare for Medicare’s planned cannabidiol pilot programs, which could establish clinical evidence and reimbursement pathways for cannabis-derived treatments.

Read more →
#95

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

This article covers legal marijuana prohibition status and regulations, which is essential for clinicians to understand their prescribing/recommendation authority and patient legal protections.

Read more →
#95

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

# Summary A Louisiana legislator proposed legalizing recreational marijuana sales via licensed dispensaries, which would expand patient access and create regulatory frameworks relevant to clinical cannabis practice.

Read more →
#92

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Summary A Georgia mother’s homemade medical cannabis formulation has been commercialized and is now available through licensed dispensaries, representing patient-developed treatment entering regulated retail markets.

Read more →
#92

Ohio THC drink ban draws lawsuit from Cincinnati breweries

# Summary Ohio’s THC beverage ban prompted legal challenges from breweries, affecting regulatory frameworks for cannabis-infused beverages that clinicians may recommend to patients.

Read more →
#92

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

# Cannabis Clinician Summary Israeli research identifies cannabis compounds with potential therapeutic application for fatty liver disease, expanding clinical evidence of cannabinoid pharmacology beyond current approved indications.

Read more →
#92

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

Virginia adult-use cannabis sales legislation has passed both legislative chambers and proceeds to conference committee, establishing regulatory framework relevant to clinicians treating cannabis patients.

Read more →
#92

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

# Summary This article examines research on medical marijuana’s therapeutic benefits and drawbacks while addressing uncertainty about its regulatory status and clinical implementation in Tennessee.

Read more →
#90

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

# Cannabis Clinician Summary The article covers proposed 2026 Utah legislation regarding cannabis, psychedelics, and kratom, relevant to clinicians assessing regulatory changes affecting patient access and treatment options.

Read more →
#90

Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails

# Summary Oregon rejected legislation that would have limited THC content in marijuana edibles to 10mg per serving, affecting dosing standardization and patient access to higher-potency cannabis products.

Read more →
#88

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

# Summary Georgia legislation proposed to restrict police use of cannabis smell as probable cause for searches, affecting legal distinctions between hemp and controlled cannabis products.

Read more →
#85

Study reveals cannabis compounds reduce threat of fatty liver disease | Health

# Summary Cannabis compounds may reduce fatty liver disease risk, providing clinicians evidence-based information for patient counseling regarding hepatic outcomes.

Read more →
#85

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

# Summary Sentence Market research projects prescription CBD oil will reach $190.9 billion by 2032, indicating significant pharmaceutical commercialization and potential clinical integration of cannabidiol products in medical practice.

Read more →
#85

TPS Cannabis News – StratCann

I don’t have access to the article content you’re referring to. Could you please share the article text or provide more details about what StratCann’s TPS Cannabis News covers? That way I can write an accurate, clinically relevant summary for you.

Read more →
#85

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

# Summary InMed Pharmaceuticals discontinued its non-therapeutic cannabis operations through BayMedica, refocusing resources on pharmaceutical development programs relevant to clinical cannabis applications.

Read more →
#85

Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots

# Summary Cannabis extracts demonstrate efficacy in reducing myofascial pain, providing clinicians with evidence-based data for patient treatment planning and therapeutic applications.

Read more →
#85

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

# Summary Pediatricians document cannabis use disorder in children and highlight accessibility barriers, providing clinicians evidence-based data on youth-related cannabis harms and prevention considerations.

Read more →
#85

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

# Summary West Virginia legislation allocates medical marijuana tax revenue, establishing funding mechanisms that affect cannabis program implementation and clinical operations.

Read more →
#85

Study highlights positive, negatives of medical marijuana – WKRN News 2

# Summary This article examines research findings on medical marijuana’s therapeutic benefits and adverse effects, providing clinicians with evidence-based information for patient treatment decisions and risk-benefit assessments.

Read more →
#85

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

# Summary This article examines roadside THC detection methods and Saskatchewan Government Insurance’s strict impaired driving policy, relevant to clinicians assessing patient cannabis use and driving safety.

Read more →
#85

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Summary A Georgia mother’s homemade medical cannabis formulation has gained commercial distribution through state dispensaries, potentially expanding patient access to established cannabis recipes.

Read more →
#85

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

# Summary Tennessee’s proposed legislation would legalize marijuana and allocate tax revenue to infrastructure, directly affecting prescribing practices and patient access for clinicians in that state.

Read more →
#85

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

# Summary A major Colorado cannabis retailer is being acquired, potentially affecting product availability, pricing, and business consolidation trends that clinicians should monitor for patient access impacts.

Read more →
#85

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

# Legalization is associated with increased marijuana use among U.S. adults, particularly affecting historically marginalized populations, requiring clinicians to assess usage patterns and related health impacts across diverse patient populations.

Read more →
#85

Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook

Ohio regulators recalled marijuana gummies missing required THC labeling symbols, affecting product safety compliance and clinician ability to verify accurate patient dosing information.

Read more →
#85

Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.

# Summary This study examines how Oregon adults perceive the health risks of marijuana versus alcohol, providing clinicians evidence of patient beliefs that may influence treatment discussions and health messaging effectiveness.

Read more →
#84

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

# Summary This article analyzes the Cannabis ETF MSOS (Marijuana Stock Opportunities ETF), providing investment market insights relevant to clinicians tracking industry financial health and accessibility of cannabis products.

Read more →
#82

Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal

# Summary Cannabis compounds show potential in reducing fatty liver disease risk, offering clinicians evidence-based information for patient consultations regarding cannabinoid therapeutic applications.

Read more →
#82

Scientists are raising new concerns about marijuana use in teens – KPBS

Adolescent cannabis use correlates with increased psychiatric risks including psychosis, depression, and anxiety, requiring clinicians to assess developmental vulnerability when treating teen patients.

Read more →
#82

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

# Summary for Cannabis Clinician A clinical trial found sublingual cannabis extracts reduced myofascial pain in temporomandibular disorder patients, expanding evidence for cannabinoid use in treatment-resistant pain conditions.

Read more →
#81

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

# Summary for Cannabis Clinicians Prenatal THC exposure disrupts fetal neurodevelopment via the endocannabinoid system; placental biomarkers may identify schizophrenia risk early, informing clinical counseling on pregnancy cannabis use.

Read more →
#81

Scientists are raising new concerns about marijuana use in teens – YouTube

This article reviews scientific evidence linking adolescent cannabis use to brain development disruptions, a critical clinical concern for practitioners treating teen and young adult patients.

Read more →
#78

A huge study finds a link between cannabis use in teens and psychosis later – NPR

A large study documents the association between adolescent cannabis use and later psychosis risk, informing clinician assessment and counseling of young patients.

Read more →
#78

Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape

Adolescent cannabis use during critical brain development periods is associated with increased risk of psychotic and bipolar disorders, which clinicians should consider when assessing psychiatric outcomes in cannabis-using youth.

Read more →
#78

Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief

# Summary for Cannabis Clinician Cannabis research now explains the neurological mechanism behind appetite stimulation, helping clinicians better understand and predict this effect in patients using cannabinoids therapeutically.

Read more →
#78

Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds

Early cannabis use during adolescence significantly increases psychotic disorder risk in adults; clinicians must screen for developmental timing and psychotic symptoms when treating cannabis-using patients.

Read more →
#78

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study examines how cannabis use affects brain reward processing, which is clinically relevant for understanding potential impacts on motivation and pleasure response in patients.

Read more →
#78

THC levels in blood and urine are “unreliable” indicators of driving impairment – leafie

THC blood/urine levels don’t reliably predict driving impairment due to THC’s lipophilic properties, complicating clinical assessment of patient safety and legal compliance.

Read more →
#78

Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph

# Summary for Cannabis Clinician Prenatal cannabis exposure may create placental biomarkers associated with offspring schizophrenia risk, informing clinical counseling for pregnant patients or those planning pregnancy.

Read more →
#78

The Endocannabinoid System’s Contribution to Placebo Analgesia – bioRxiv

# Summary for Cannabis Clinicians The endocannabinoid system mediates placebo analgesia, indicating that expectation-based pain relief activates similar cannabinoid pathways as cannabis therapeutics, informing treatment response mechanisms.

Read more →
#78

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …

This article examines how endocannabinoid system modulation through CB1/CB2 receptors may address neurobiological dysfunctions in alcohol use disorder, relevant for clinicians considering cannabis-based therapeutic approaches.

Read more →
#78

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill

Cannabis hyperemesis syndrome causes severe cyclic nausea and vomiting in chronic users; clinicians must recognize it to avoid misdiagnosis and unnecessary interventions.

Read more →
#78

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

This research compares psychiatric outcomes of cannabis use disorder to other substance use disorders, helping clinicians assess relative clinical burden amid evolving legal and cultural contexts.

Read more →
#78

Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …

# Cannabis Clinician Summary Research indicates lifetime cannabis use shows no association with cognitive decline or dementia in older adults, potentially reassuring clinicians regarding long-term neurological safety in this population.

Read more →
#78

Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults

# Summary for Cannabis Clinician This study provides evidence that lifetime cannabis use does not accelerate cognitive decline or increase dementia risk in older adults, informing clinical safety assessments for this population.

Read more →
#78

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabinoid compounds with potential therapeutic activity against non-alcoholic fatty liver disease, currently lacking approved medications, offering clinicians a possible new treatment option.

Read more →
#78

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

# Summary Sentence The article examines barriers preventing international cannabis companies from entering the U.S. market, relevant to clinicians navigating evolving regulatory landscapes affecting drug availability and patient access.

Read more →
#78

North Shore Dispensary opens in Duluth’s Lincoln Park – WDIO.com

# Summary A cannabis dispensary opened in Duluth’s Lincoln Park neighborhood, expanding local patient access to regulated cannabis products in Minnesota.

Read more →
#78

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic

Cannabis clinicians should understand that THC and CBD may protect against non-alcoholic fatty liver disease by reducing hepatic inflammation and fibrosis through endocannabinoid system modulation.

Read more →
#76

Observational study on medical marijuana use seeks Arizona participants – KJZZ

# Summary for Cannabis Clinician An observational study in Arizona collects real-world medical cannabis use data to complement controlled trials and inform clinical practice across diverse patient conditions and consumption methods.

Read more →
#76

Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC

# One-Sentence Summary Preclinical research suggests CBD and CBG may reduce liver fat accumulation through endocannabinoid receptor interactions, potentially offering cannabinoid-based therapeutic options for fatty liver disease management.

Read more →
#75

A huge study finds a link between cannabis use in teens and psychosis later – KUOW

# Summary for Cannabis Clinician Longitudinal research demonstrates adolescent cannabis use correlates with increased adult psychosis risk, relevant for clinical assessment and patient counseling on developmental vulnerability.

Read more →
#75

Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW

This research examines how medical cannabis affects driving safety by investigating THC’s impact on psychomotor skills and reaction time—critical information for clinicians counseling patients on safe use.

Read more →
#75

Cannabis research: India to start human trials for medicinal marijuana – NewsBytes

India is initiating human clinical trials for medicinal cannabis to establish safety and efficacy data, marking a policy shift relevant to clinicians seeking evidence-based dosing and therapeutic applications.

Read more →
#75

Cannabis Munchies Driven by Brain Reward Signals | Technology Networks

# Summary for Cannabis Clinician Cannabis activates brain reward pathways that drive increased appetite; understanding this mechanism helps clinicians counsel patients on appetite effects and manage related clinical outcomes.

Read more →
#75

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study examines how THC affects developing brain reward systems over time, providing clinicians evidence-based data on cannabis’s neurobiological effects relevant to patient assessment and counseling.

Read more →
#75

Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users

# Cannabis Clinician Summary Cannabinoid hyperemesis syndrome causes severe cyclical nausea and vomiting in chronic heavy cannabis users; clinicians must recognize this paradoxical condition to properly diagnose and counsel affected patients.

Read more →
#75

Study finds no links between cannabis use and cognitive decline or dementia in older people

This article reports research challenging the assumption that cannabis use causes cognitive decline or dementia in older adults, which directly impacts clinical risk-benefit discussions with this population.

Read more →
#75

Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest

# Summary for Cannabis Clinicians This article examines biobank research linking cannabis use to brain aging trajectories, providing clinicians evidence-based data on neurobiological effects relevant to patient counseling and treatment planning.

Read more →
#75

Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie

This study challenges the assumption that cannabis use causes cognitive decline in older adults, informing clinical decisions about cannabis recommendations for this patient population.

Read more →
#75

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com

# Summary for Cannabis Clinician Research indicates CBD and THC may reduce liver fat accumulation and inflammation in metabolic-associated steatotic liver disease, potentially expanding therapeutic applications in hepatic metabolic disorders.

Read more →
#74

Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …

# Cannabis Clinician Summary Prenatal cannabis exposure alters placental gene expression patterns linked to schizophrenia risk, providing clinicians with potential biomarkers for identifying at-risk pregnancies.

Read more →
#72

Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes

This study documents the association between adolescent cannabis use and psychiatric disorder risk, informing clinicians’ need for early screening and intervention in young patients.

Read more →
#72

A huge study finds a link between cannabis use in teens and psychosis later – WBAA

# Cannabis Clinician Summary A large study demonstrates adolescent cannabis use increases later-life psychosis and depression risk, supporting clinical guidance to discourage teen use during critical brain development.

Read more →
#72

Researcher: Remediated cannabis may still have harmful mold – MJBizDaily

Remediated cannabis may retain undetected mold despite passing state tests, posing health risks to immunocompromised patients that clinicians need to consider when recommending products.

Read more →
#72

So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?

This article identifies clinical risk factors for cannabis dependence in adults, helping physicians determine which patients can safely use cannabis therapeutically with minimal dependence risk.

Read more →
#72

Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube

Cannabis hyperemesis syndrome is increasing in Virginia ERs, presenting clinicians with a real clinical condition requiring recognition and management of cyclical vomiting, nausea, and abdominal pain in frequent users.

Read more →
#72

Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …

Veterans with substance use disorders report using cannabis to manage pain, anxiety, and sleep issues during SUD treatment, providing clinicians relevant data on cannabis use patterns in this population.

Read more →
#72

ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView

# Summary Artelo Biosciences develops targeted cannabinoid therapeutics for medical conditions like cancer anorexia and chemotherapy neuropathy, representing pharmaceutical-grade drug development beyond whole-plant cannabis.

Read more →
#72

Bill to protect Nebraska physicians recommending medical cannabis advances to floor

# Summary Sentence Nebraska’s bill protects physicians from professional consequences when recommending medical cannabis, removing a key barrier that previously deterred qualified doctors from participating in cannabis medicine.

Read more →
#72

Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical …

This research examines how cannabis use interacts with alcohol, caffeine, exercise, and sleep to affect anxiety in medical patients, helping clinicians understand complex factors influencing treatment outcomes.

Read more →
#72

Nebraska bill to protect healthcare practitioners who recommend medical cannabis sails out of com…

Nebraska legislation protects healthcare providers recommending medical cannabis, addressing liability concerns as states align regulations with voter-approved medical cannabis programs.

Read more →
#72

Major study finds strong link between cannabis, anxiety and depression – Medical Xpress

This study documents associations between cannabis use and anxiety/depression, highlighting the clinical challenge of determining whether cannabis causes these conditions or users self-medicate with it.

Read more →
#72

Research: Munchies May Aid Those Lacking Appetite – Pullman Today

Cannabis activates CB1 receptors in hunger-regulating brain regions to stimulate appetite, offering potential therapeutic value for patients with appetite loss due to medical conditions or treatments.

Read more →
#72

President Biden Signs Historic Cannabis Research Bill – Ganjapreneur

# Summary for Cannabis Clinician This article covers President Biden’s signing of federal cannabis research legislation that removes regulatory barriers, enabling expanded clinical investigation into cannabinoids and their therapeutic applications.

Read more →
#72

Marijuana Use & Dangers for Adolescents & Young Adults

This article examines cannabis effects on adolescent and young adult brains during critical developmental periods and addresses cannabis use disorder comorbidity, which clinicians must understand to treat this vulnerable population.

Read more →
#72

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com

Cannabis hyperemesis syndrome causes severe nausea and vomiting in chronic heavy users, requiring clinicians to recognize this paradoxical condition when treating long-term cannabis patients.

Read more →
#72

Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …

Adolescent cannabis use, even at low frequency (monthly or less), correlates with academic decline and disruption, informing clinician counseling on use risks.

Read more →
#72

Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de

# Summary Pharmaceutical companies are developing targeted cannabinoid drugs that modulate specific receptor pathways, representing a shift from whole-plant cannabis toward precision medicine approaches relevant to clinical practice.

Read more →
#72

Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML

This study examines whether long-term cannabis use affects cognitive decline and dementia risk in older adults, important for clinicians counseling patients about safety and long-term health outcomes.

Read more →
#72

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

CBD-dominant cannabis products show clinical efficacy for anxiety relief, providing clinicians an evidence-based option for patients seeking symptom management with lower psychoactive effects than THC-dominant formulations.

Read more →
#72

Toronto police shutdown multiple unlicensed cannabis dispensaries – CP24

# Summary Toronto police closed unlicensed cannabis dispensaries, affecting patient access to unregulated products that lack quality assurance and clinical oversight clinicians depend on for safe recommendations.

Read more →
#72

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

# Summary Response This article examines the relationship between cannabis use as an alcohol reduction tool and working memory capacity, relevant to clinicians assessing cannabis substitution strategies’ efficacy in individual patients.

Read more →
#72

Kentucky bill would change how alcohol, cannabis beverages are taxed – WKYT

# Summary Kentucky legislation proposes tax restructuring for alcohol and cannabis beverages, affecting product pricing and market accessibility for patients in clinical cannabis programs.

Read more →
#72

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries – WALB

# Summary A Georgia mother’s homemade medical cannabis formulation has gained commercial distribution through state dispensaries, demonstrating consumer-developed cannabis products entering regulated markets.

Read more →
#72

Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

# Summary The WSJ article examines media coverage of teen cannabis use trends, relevant to clinicians monitoring youth cannabis epidemiology and public perception shaping clinical prevention discussions.

Read more →
#72

Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune

# Summary This article examines increasing clinical and public confidence in cannabidiol (CBD) oil, relevant to clinicians evaluating evidence-based cannabinoid therapeutics and patient education.

Read more →
#72

Cannabis payouts drop for most Oakland County communities

# Summary Oakland County cannabis tax revenues decreased for most municipalities, directly affecting local funding for regulatory oversight and cannabis clinic operations.

Read more →
#72

New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

# Summary A licensed cannabis dispensary has opened on Route 22 in Somerville, expanding patient access to regulated cannabis products in the New Jersey area.

Read more →
#72

Cannabis use by teenagers doubles their risk of developing psychotic and bipolar disorders

# Summary Cannabis use during adolescence is associated with doubled risk of psychotic and bipolar disorders—critical information for clinicians assessing psychiatric comorbidities and counseling young patients about potential mental health consequences.

Read more →
#72

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug

# Summary Pediatricians highlight concerns about cannabis use disorder in children and barriers to prevention, directly relevant to clinicians managing adolescent cannabis-related conditions.

Read more →
#71

Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar

# Summary for Cannabis Clinician Adolescent cannabis use carries elevated psychiatric risks—specifically psychosis and bipolar disorder—compared to adult use, reflecting critical neurodevelopmental vulnerability periods clinicians must assess during patient intake.

Read more →
#70

Can You Drive the Next Morning After Weed? Study Finds No Significant Impairment 12–15 …

This article examines next-day driving safety after cannabis use, addressing clinician concerns about residual impairment, individual metabolic variation, and tolerance factors relevant to patient counseling.

Read more →
#68

Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED

Medicare may cover cannabis-based medications for seniors with conditions like chronic pain and neuropathy, potentially expanding clinical access and legitimizing cannabinoid therapeutics in mainstream healthcare.

Read more →
#68

Placenta May Hide Early Warning Signs of Schizophrenia Risk – ScienceAlert

# Preclinical research suggests prenatal THC exposure may create placental biomarkers associated with schizophrenia risk, highlighting the need for clinicians to counsel pregnant patients about potential neurodevelopmental effects. (39 words)

Read more →
#68

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# Medical Cannabis Regulatory Standards Medical cannabis prescribers face the same regulatory and accountability requirements as other physicians, making proper documentation and clinical reasoning essential to practice legally and safely.

Read more →
#68

Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News

A Canadian study documents concurrent increases in cannabis use and anxiety/depression diagnoses, prompting clinicians to assess potential associations between cannabis and mood disorder outcomes in their patient populations.

Read more →
#68

A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

This article discusses integrating digital therapeutic tools into cannabis medicine to enable outcome measurement, personalized dosing, and structured clinical protocols for improved patient care.

Read more →
#68

Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial

# Summary for Cannabis Clinicians Ananda Pharma is initiating an NHS-backed clinical trial testing CBD for endometriosis pain management, addressing a significant unmet medical need affecting millions of women globally.

Read more →
#68

Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals

This legislation permits terminally ill patients to use medical cannabis in hospital settings, resolving a conflict between state cannabis law and hospital policies that currently prohibit it.

Read more →
#68

Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids

This article examines how non-psychoactive cannabinoids interact with the endocannabinoid system to potentially address neurodegeneration through anti-inflammatory and neuroprotective mechanisms relevant to clinical practice.

Read more →
#65

America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …

This article addresses gaps in medical education regarding cannabis therapeutics and argues that clinical training deficiencies, not the plant itself, underlie mainstream concerns about cannabis use.

Read more →
#65

Are My THC Gummies Going Away? – Science Friday

# Summary for Cannabis Clinician Federal lawmakers are scrutinizing the legal loophole for hemp-derived THC gummies created by the 2018 Farm Bill, which matters because potential regulatory changes could affect patient access to these products.

Read more →
#65

House panel approves proposed medical cannabis law – POLITIKO

The Philippine House advances medical cannabis legislation establishing regulated research and patient access frameworks, expanding treatment options in a traditionally restrictive drug policy environment.

Read more →
#65

What effects does THC have on youth who dabble? – YouTube

# One-Sentence Summary THC exposure during adolescence may affect developing brain regions critical for decision-making and emotion regulation, making this clinician knowledge essential for assessing developmental risks in young patients.

Read more →
#65

Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube

# Summary for Cannabis Clinician Tennessee hemp regulation is restricting access to full-spectrum CBD products that dystonia patients rely on for symptom management, raising clinical concerns about medication availability.

Read more →
#65

“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A – Cannabis Health News

# Summary Sentence This article examines CBG and CBGA’s emerging therapeutic potential in anxiety, memory, and cancer treatment, relevant to clinicians considering cannabinoid compounds beyond THC and CBD.

Read more →
#65

Ghana launches medicinal cannabis programme under strict regulation

Ghana’s medicinal cannabis regulatory programme enables structured clinical research in West Africa, potentially generating population-specific efficacy and safety data for cannabis-based medicines.

Read more →
#65

Patient Protect launches to tackle discrimination against UK medical cannabis patients

Medical cannabis patients in the UK face discrimination in housing, employment, and driving despite legal prescriptions, requiring clinicians to understand patients’ broader social challenges.

Read more →
#65

Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report

# Summary Sentence This research examines cannabis use’s association with mental health outcomes in older adults, informing clinicians about substance-cognitive health interactions in geriatric populations.

Read more →
#65

Natural Approaches to Managing Chronic Inflammation – WorldHealth.net

# Summary for Cannabis Clinician This article explains how the endocannabinoid system regulates inflammation and immune function, and how plant cannabinoids like CBD and THC interact with these mechanisms—essential knowledge for clinical cannabis practice.

Read more →
#64

Alabama medical cannabis program is now accepting patient registrations! – Blog

Alabama’s medical cannabis program enables clinicians to recommend cannabis for qualifying conditions including chronic pain, PTSD, anxiety, and cancer symptoms, expanding treatment options in a traditionally restrictive state.

Read more →
#64

House panel revives medical cannabis bill – Daily Tribune

The Philippines is establishing regulated medical cannabis framework, enabling clinicians to legally prescribe cannabis for therapeutic purposes in a previously restrictive jurisdiction.

Read more →
#62

More Kentucky children dying to ‘preventable’ overdoses, new report shows

This article reports increased pediatric cannabinoid overdoses in Kentucky, emphasizing that clinicians should counsel cannabis-using patients on secure storage to prevent accidental child exposure.

Read more →
#62

Legislation on medical cannabis: DOH bares conditions – Cebu Daily News

The Philippines’ Department of Health is establishing evidence-based regulatory conditions for medical cannabis legalization, directly shaping clinical access and prescribing frameworks for healthcare providers.

Read more →
#62

Sober shift could reshape spending, but doctor warns THC may be the new vice – Fox Baltimore

This article examines the public health implications of Americans substituting cannabis for alcohol and whether this shift represents genuine health improvement or substance substitution.

Read more →
#62

Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram

Secondhand marijuana smoke contains particulate matter triggering respiratory inflammation and asthma exacerbation, requiring clinicians to counsel patients on exposure risks similar to tobacco smoke.

Read more →
#62

Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV

Nebraska’s medical cannabis commission established emergency regulations capping patient THC possession at 5 grams—a threshold potentially insufficient for therapeutic dosing in qualifying conditions.

Read more →
#62

Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest

Nebraska legislation would protect physicians recommending medical cannabis from arrest, enabling doctors to practice medicine without criminal liability concerns.

Read more →
#62

The Week in Weed: February 27, 2026 – Lexology

# Summary for Cannabis Clinicians Researchers documented measurable physiological and psychoactive responses to acute cannabis use, providing evidence clinicians need to understand cannabis effects on patients.

Read more →
#62

First-of-its-kind long-term study at Virginia Tech shares how cannabis use can affect driving

# Cannabis and Driving Performance This Virginia Tech study examines how THC impairs driving abilities non-linearly, highlighting why current roadside testing methods are inadequate for cannabis-impaired driving assessment.

Read more →
#62

Expert breaks down hidden dangers of doctors prescribing medical marijuana – UNILAD

This article addresses Cannabis Use Disorder prevalence in medical contexts and concerns about physician prescribing practices, which are clinically relevant for patient assessment and treatment planning.

Read more →
#62

Hemp article tells us why WI needs government regulations | Letter – Milwaukee Journal Sentinel

# One-Sentence Summary Wisconsin’s unregulated hemp market lacks testing and labeling standards for THC content, creating consumer safety risks that clinicians must understand when counseling patients.

Read more →
#62

Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law

# One-sentence summary: This article documents a campaign honoring a mother’s advocacy role in legalizing medical cannabis in the UK, focusing on cannabidiol’s evidence-based efficacy for drug-resistant childhood epilepsy.

Read more →
#62

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

# Summary for Cannabis Clinician A new cannabis medicine group is advocating for federal policy decisions on cannabinoid therapy to be based on scientific evidence and patient input during rescheduling discussions.

Read more →
#62

Hey Sonar: Rethinking your relationship with weed – CSU Signal

# Summary This article examines cannabis use patterns and relationship dynamics, providing clinicians insight into how users conceptualize their consumption habits—relevant for patient counseling and behavioral assessment.

Read more →
#62

‘Green lab’ helps Oregon officers recognize marijuana-impaired driving | The Astorian

# Summary Oregon law enforcement uses a “green lab” training program to help officers identify marijuana-impaired driving, which is clinically relevant for understanding cannabis impairment assessment and its public health implications.

Read more →
#62

Medical marijuana as someone working in healthcare industry : r/florida – Reddit

# Summary This Reddit discussion covers healthcare workers’ experiences with medical marijuana in Florida, providing practical perspectives relevant to clinical practice and professional considerations in the healthcare setting.

Read more →
#60

Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE

# Cannabis Clinician Summary Kansas Legislature is considering medical and recreational marijuana legalization, which would create patient access frameworks and clinical practice opportunities in a currently prohibited state.

Read more →
#60

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

# Cannabis Article Summary Medical cannabis legislation in Tennessee faces uncertain progress despite Republican lawmakers’ recent openness to reform, with clinical evidence supporting multiple therapeutic applications.

Read more →
#58

The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook

The Philippines is developing medical cannabis legislation with regulatory frameworks and research provisions, enabling clinicians to legally treat qualified patients with cannabis therapeutics.

Read more →
#58

Health advocate underscores ‘real danger’ in medical cannabis legalization in PH

This article examines Philippine healthcare system concerns about implementing medical cannabis regulation, relevant to clinicians needing understanding of jurisdictional regulatory frameworks and oversight requirements.

Read more →
#58

Extended moratorium on Oklahoma medical marijuana business licenses approved by House

Oklahoma’s House approved an extended moratorium on medical marijuana business licenses to address market oversaturation and resulting regulatory and quality control challenges.

Read more →
#58

MS Senate committee approves one medical marijuana bill, rejects another

Mississippi’s Senate committee debates expanding medical cannabis access by broadening patient eligibility criteria and permitting hospital-based administration, directly affecting clinical practice scope.

Read more →
#58

Major Canadian Study Reveals Significant Connection Between Cannabis Use, – Bioengineer.org

# Summary for Cannabis Clinician This research documents the bidirectional relationship between cannabis use and mood disorders, establishing that clinicians must assess both cannabis as a potential risk factor and as self-medication in anxious or depressed patients.

Read more →
#58

DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL … – StreetInsider

# Summary for Cannabis Clinician This covers QuickStrip™, a sublingual thin-film delivery system that bypasses first-pass metabolism, potentially improving CBD onset speed and absorption consistency compared to oral formats.

Read more →
#58

420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI

# Summary Sentence Cannabis-impaired driving poses public health risks due to THC’s effects on motor function and reaction time, making this a critical clinical concern for patient safety counseling and legal implications.

Read more →
#58

Recreational Marijuana – Cons | Britannica

# Summary Sentence This article examines the pharmacological interaction between cannabis and alcohol, including evidence that THC may reduce acute alcohol consumption, which is clinically relevant for treating alcohol use disorders.

Read more →
#58

Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026)

# Cannabis Clinician Summary Federal agencies warn that drug tests cannot reliably distinguish medical cannabis from legal hemp products, creating clinical and legal complications for patient care and employment screening.

Read more →
#57

Recreational Marijuana – Cons | Britannica

# Summary This article examines documented disadvantages of recreational marijuana legalization, providing clinicians with evidence-based information about potential harms relevant to patient counseling and public health assessment.

Read more →
#57

These Maine towns have the most cannabis businesses – The County

# Summary This article identifies Maine towns with the highest concentration of cannabis businesses, providing clinicians with geographic data on local market saturation and accessibility that may inform patient counseling about product availability and retail proximity.

Read more →
#55

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

The Philippine Department of Health is establishing regulatory conditions for medical cannabis legalization, including compassionate access and research frameworks relevant to clinical practice.

Read more →
#55

Building a global standard for cannabis vapes one terpene at a time – MJBizDaily

# Cannabis Vape Standardization This article addresses efforts to establish global terpene content standards for cannabis vapes, which matters because terpene profiles may influence therapeutic effects through cannabinoid interactions.

Read more →
#55

Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores

# Clinical Summary Low-dose THC beverages have distinct absorption and onset kinetics compared to inhaled cannabis, requiring clinicians to adjust dosing guidance and patient counseling accordingly.

Read more →
#55

How a virtual medical cannabis clinic is working on healthcare coverage for THC

# Cannabis Article Summary This article examines how virtual medical cannabis clinics are expanding insurance coverage for THC-based treatments by positioning cannabis as a cost-reducing healthcare intervention rather than just symptom management.

Read more →
#55

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovered after telemedicine restrictions forced patients to attend in-person consultations, demonstrating how regulatory changes impact patient access and market dynamics.

Read more →
#55

DPH Commissioner goes ‘On the Record’ about measles outbreaks, cannabis – YouTube

Public health officials warn about elevated THC potency in legal cannabis products and associated risks for adolescent exposure, relevant to clinicians assessing patient safety and developmental impacts.

Read more →
#55

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

This article examines U.S. federal cannabis scheduling barriers that complicate medicine development for clinicians seeking evidence-based cannabinoid therapeutics.

Read more →
#55

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s updated cannabis regulations integrate medical cannabis into formal healthcare and permit domestic cultivation under health authority oversight, enabling clinicians to access standardized products within regulated systems.

Read more →
#55

Branford industrial site sold, to become cannabis growing operation – The Wilton Bulletin

# Summary An industrial property in Branford was sold and will be converted into a cannabis cultivation facility, affecting local supply chain infrastructure and potential product availability for clinical programs.

Read more →
#52

Most cannabis users are ‘non-problematic’, Canadian data shows – leafie

# One-Sentence Summary Most Canadian cannabis users don’t show problematic patterns, suggesting clinicians should focus assessments on identifying the minority with actual use disorders rather than assuming pathology.

Read more →
#52

US Cannabis Rescheduling: A Victory or a Federal Trap?

Federal rescheduling from Schedule I to III changes DEA classification but leaves state cannabis programs in legal limbo, requiring clinicians to understand evolving FDA regulatory implications.

Read more →
#52

Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform

# Summary for Cannabis Clinicians Rapid Dose Therapeutics is developing oral thin film technology to deliver cannabinoids with improved dosing precision and faster onset compared to traditional methods.

Read more →
#52

Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most

Cannabis clinicians need to understand that THC alters specific food preferences toward high-calorie, high-fat and high-sugar options, enabling better patient counseling on dietary management and metabolic effects.

Read more →
#52

Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week

Congressional committee is voting to delay federal hemp-derived THC product ban, highlighting regulatory gaps in product safety, labeling, and dosing that clinicians need to address with patients.

Read more →
#52

Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp

Wisconsin Democrats proposed legislation establishing adult-use and medical cannabis programs with Department of Health Services oversight, directly affecting clinical cannabis practice and patient access.

Read more →
#52

Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …

# Summary for Cannabis Clinician CBC is a non-intoxicating cannabinoid with distinct endocannabinoid system mechanisms that may offer clinical alternatives to CBD/THC, relevant for mood-focused patient treatment options.

Read more →
#52

Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty

# Cannabis Clinician Summary Maryland delayed voting on legislation permitting firefighters to use medical cannabis off-duty for occupational-related conditions like chronic pain, PTSD, and sleep disorders.

Read more →
#52

Upper Township unanimous for weed zone, overriding complaints from residents

# Summary Upper Township unanimously approved a cannabis retail zone despite resident opposition, establishing a legal sales area that clinicians should monitor for local patient access changes.

Read more →
#50

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

This article covers medical cannabis delivery app expansion in the DC-Maryland-Virginia region and Jamaica, highlighting accessibility improvements for patients with mobility or health limitations.

Read more →
#50

Cannabis industry launches organization to further US policy changes with members from …

# Cannabis Industry Coalition Formation A cannabis industry coalition has formed to influence US federal rescheduling policy discussions, which affects regulatory clarity for clinical practitioners and patient access to cannabis treatments.

Read more →
#48

The Best CBD for Seniors in 2026: Safe, Lab-Tested, and Easy to Use | stupidDOPE

This article reviews CBD products marketed to seniors for managing pain, sleep, and anxiety—clinically relevant for understanding patient preferences and safety considerations in older adults.

Read more →
#48

Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com

Indiana’s missed legislative deadline killed cannabis reform, leaving the state without updated policy while neighboring states expand patient access programs.

Read more →
#48

Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds

# Cannabis Clinician Summary Unregulated hemp products pose clinical risks through mislabeled THC content, mold, pesticide, and carcinogen contamination, requiring clinicians to counsel patients on safety concerns and testing limitations.

Read more →
#48

Many NC candidates support medical marijuana legalization | Raleigh News & Observer

North Carolina candidates show bipartisan support for medical marijuana legalization, relevant to clinicians as it signals potential policy changes affecting patient access and clinical practice in the state.

Read more →
#48

Does Weed Make You Harder or Easier to Manipulate? – Herb

# Clinical Summary Cannabis impairs prefrontal cortex function affecting judgment and decision-making; clinicians should assess dose-dependent cognitive effects when evaluating patient safety and informed consent capacity.

Read more →
#48

Aelis Farma’s AEF0117 THC Interaction Trial Withdrawn: What Investors Should Know

Aelis Farma withdrew a clinical trial of AEF0117, a CB1 receptor inhibitor intended to mitigate THC adverse effects, affecting a potential therapeutic option for cannabis use disorder management.

Read more →
#48

Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire

# Summary for Cannabis Clinician This article covers potential federal policy changes affecting cannabis scheduling and international pharmaceutical-grade cannabis markets, which may impact clinical access and standardization of cannabis-based medicines.

Read more →
#48

Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To …

# Summary for Cannabis Clinician Veterans organizations advocate expanding VA access to cannabis and psychedelics to address veteran suicide rates, reflecting clinical evidence gaps in current treatments.

Read more →
#47

The Fire Station partners with Citizens for a Safe & Clean Lake Superior for cannabis vape …

# Summary The Fire Station partners with a community organization regarding cannabis vape products, potentially addressing product safety, testing, or public health concerns relevant to clinical cannabis practice.

Read more →
#45

Boulder and CBD: The Entourage Effect Explained | About Boulder County Colorado

# Cannabis Clinician Summary The entourage effect explains how whole-plant cannabis formulations produce different therapeutic outcomes than isolated cannabinoids, which is clinically relevant for treatment selection and patient outcomes.

Read more →
#45

Indiana S.B. 250 could close Lafayette hemp-beverage sales without a key amendment

Indiana S.B. 250 could eliminate legal hemp-derived cannabinoid beverage sales, affecting patient access to regulated products currently used for symptom management.

Read more →
#45

The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008

# Summary for Cannabis Clinician This article reviews CBD’s mechanisms for immune support via the endocannabinoid system’s role in regulating inflammation and homeostasis, relevant to clinical cannabinoid therapeutics.

Read more →
#45

Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News

Louisiana is advancing an adult-use cannabis pilot program, providing clinicians data on sales patterns and public health outcomes in a previously restrictive state.

Read more →
#45

As Congress debates hemp-derived THC ban, Pa. lawmakers look for other options

# Summary for Cannabis Clinician Pennsylvania lawmakers are developing regulatory frameworks for hemp-derived THC products that exist in a federal-state legal gray zone, affecting patient access and clinical product standardization.

Read more →
#45

West Virginia House approves bill allowing medical cannabis edibles | WV News

West Virginia approved medical cannabis edibles, expanding patient access to alternative delivery methods beyond traditional inhalation for managing various conditions.

Read more →
#45

The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com

Alabama’s medical cannabis program launching in April expands treatment options for qualifying patients with chronic pain, PTSD, and anxiety, requiring clinicians to understand new regulatory protocols and patient eligibility criteria.

Read more →
#45

Branford industrial site sold, to become cannabis growing operation – New Haven Register

# Summary An industrial site in Branford was sold and will be converted into a cannabis cultivation facility, expanding local production capacity and supply infrastructure.

Read more →
#42

Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health

# Summary Utah lawmakers approved clinical trials of psychedelics for veterans’ mental health, expanding research access beyond cannabis to alternative psychoactive substances for treating PTSD and related conditions.

Read more →
#42

The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008

# Summary for Cannabis Clinician This article reviews CBD’s mechanisms of action on multiple receptor systems (cannabinoid and non-cannabinoid) relevant to cognitive and mood effects, addressing clinical interest in CBD’s potential therapeutic applications.

Read more →
#42

Study uncovers another reason not to skimp on sleep – ASU News

Sleep deprivation impairs prefrontal cortex function, increasing impulsive decision-making and substance use risk—clinicians should assess sleep quality when evaluating cannabis use patterns and relapse risk.

Read more →
#42

OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany

# Summary for Cannabis Clinician The New York State Office of Cannabis Management recalled select products due to Keystone Lab testing integrity concerns, affecting clinician ability to verify product safety and cannabinoid accuracy for patient recommendations.

Read more →
#42

High Tide joins U.S. National Compassionate Care Council | HITI Stock News

High Tide’s membership in the U.S. National Compassionate Care Council signals industry participation in advocacy for standardized, evidence-based medical cannabis access policies.

Read more →
#42

Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply

Oklahoma’s permissive medical cannabis licensing created regulatory gaps affecting dispensary oversight and product safety, directly impacting clinician ability to recommend quality-assured cannabis therapeutics.

Read more →
#42

SA risks missing R40bn hemp industry opportunity without coherent strategy – Business Day

South Africa’s hemp industry lacks coordinated national strategy, risking R40 billion in potential revenue from CBD products and industrial applications that could expand patient access to cannabis-based therapeutics.

Read more →
#42

Kearney man charged with selling THC cartridges to undercover officer near school – Nebraska TV

# Summary A Kearney resident faced charges for selling THC cartridges to an undercover officer near a school, illustrating enforcement of cannabis regulations and proximity restrictions relevant to clinical practice settings.

Read more →
#40

The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …

# Cannabis Product Safety This article covers regulated cannabis product recalls due to failed safety testing by Keystone laboratories, which matters to clinicians ensuring patients receive contaminant-free medicine.

Read more →
#40

Linnea Achieves CEP Certification for Cannabidiol Isolate – Morningstar

# CEP Certification for Cannabidiol Isolate Linnea’s cannabidiol isolate achieved European Pharmacopoeia certification, ensuring standardized identity, purity, and manufacturing consistency—critical for clinical reliability and regulatory compliance in medical cannabis applications.

Read more →
#40

Substance use on the rise among Gen Z in their early 20s – Medical Xpress

# Summary Substance use increases among Gen Z young adults represent emerging clinical trends that cannabis clinicians should monitor for epidemiological patterns and potential treatment demand shifts.

Read more →
#38

Senate Bill would repeal 24% wholesale tax on marijuana – WTVB

# Cannabis Clinician Summary Senate legislation proposes eliminating a 24% wholesale marijuana tax enacted January 2026, addressing industry concerns about tax burden sustainability.

Read more →
#38

R40bn opportunity for hemp industrialisation in South Africa requires policy support – LSF study

South Africa’s hemp industrialization could generate R40 billion economically, but requires government policy support—relevant to clinicians as regulatory frameworks directly impact medical cannabis availability and research opportunities.

Read more →
#38

Bill to require stricter packaging requirements for marijuana edibles dies in Oregon legislature

A failed Oregon bill proposed individual wrapping and standardized dosing for cannabis edibles to prevent accidental pediatric ingestion and improve product safety standards.

Read more →
#35

Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN

Germany’s medical cannabis market growth is documented through patient outcome data, providing clinicians evidence-based information on therapeutic effectiveness and treatment trends.

Read more →
#35

New study reveals how many Americans use CBD — and why | GreenState

A study provides epidemiological data on CBD usage patterns and demographics across the American population, helping clinicians understand patient prevalence and primary use cases.

Read more →
#35

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovery demonstrates regulatory progress enabling physician access to cannabis therapeutics for patients in a major European jurisdiction.

Read more →
#35

Wisconsin Democrats Introduce Cannabis Legalization Bill – Law360 Tax Authority

Wisconsin Democrats introduced legislation to legalize recreational cannabis and establish regulatory/tax frameworks, relevant to clinicians for understanding evolving legal landscape affecting patient access and clinical practice.

Read more →
#35

CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …

Two sisters report quality-of-life improvements using full-spectrum CBD hemp oil containing THCA, while highlighting regulatory concerns affecting product accessibility.

Read more →
#35

ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)

# Cannabis Clinician Summary Federal cannabis prohibition’s intersection with Second Amendment rights may affect patient record-keeping and liability documentation for clinicians treating state-legal cannabis users.

Read more →
#35

Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows

Texas voters disapprove of state marijuana/THC regulation management, signaling demand for policy clarity that directly impacts clinicians’ ability to recommend cannabis therapeutically.

Read more →
#35

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# One-Sentence Summary This article examines the tension between clinical practice demands and regulatory constraints in medical cannabis, emphasizing the need for standardized outcome accountability measures.

Read more →
#35

March 5 webinar offers parents lessons on drug/alcohol trends – Rice County, MN

# Cannabis Clinician Summary A Rice County webinar educates parents on current youth drug/alcohol trends and cannabis health impacts, helping clinicians understand community awareness gaps and parental knowledge needs.

Read more →
#35

Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)

Michigan’s high cannabis tax rates are driving consumers to illicit markets, reducing legal sales and revenue—a key consideration for clinicians counseling patients on product safety and legal access.

Read more →
#35

Curaleaf Earnings: International Growth Offsets Domestic Decline from Continued Price Compression

Curaleaf’s earnings show legal cannabis retailers losing domestic market share to illicit competitors and unregulated hemp products, affecting industry viability and patient access to regulated products.

Read more →
#35

Kentucky bill would expand cannabis drink sales beyond liquor stores – WKYT

Kentucky’s SB 223 establishes regulatory frameworks for cannabis-infused beverage sales across multiple retail channels, which matters clinically for standardizing dosing, labeling, and patient access documentation.

Read more →
#35

Advanced drug testing improves patient care at MUSC

Advanced drug testing at MUSC enables more accurate, cost-effective THC detection, allowing clinicians to better assess patient cannabis use and personalize treatment plans.

Read more →
#35

As lawmakers in Richmond continue debating a path forward for retail marijuana sales …

Virginia lawmakers debate retail marijuana regulations despite limited state-specific research on health and social impacts, creating evidence gaps that affect clinical practice guidelines and patient care standards.

Read more →
#35

Europe’s Medical Cannabis Market Surges Toward $13 Billion: Last Week in Weed Feb. 23 …

Europe’s medical cannabis market growth to $13 billion reflects expanding regulatory frameworks and commercial availability, directly impacting clinician access to pharmaceutical-grade products for patient treatment.

Read more →
#35

Facing Hemp Ban, PA Lawmakers Race to Regulate THC Drinks and Products

Pennsylvania is developing regulations for THC-infused beverages and hemp products amid increased federal enforcement, which affects patient access to legal cannabis products and clinical practice standards.

Read more →
#35

Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws

# Cannabis Clinician Relevance Senator Ricketts’ non-committal stance on federal protections for state medical cannabis laws creates legal uncertainty for Nebraska clinicians prescribing cannabis therapeutically.

Read more →
#35

The Wait is Over: Medical Cannabis set to roll out in April | WKRG.com

Alabama’s medical cannabis program launches in April with regulated dispensary sales, providing clinicians access to a legal framework for recommending cannabis products to eligible patients.

Read more →
#35

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Summary for Cannabis Clinician The FDA is escalating enforcement against cannabis beverage companies making unsubstantiated health claims, directly affecting clinical credibility and patient safety guidance.

Read more →
#35

Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows

# Summary This article discusses research on diabetes medications’ potential therapeutic applications for treating multiple substance addictions, relevant to clinicians managing cannabis use disorder comorbidities.

Read more →

Also Noted

#25

Bridgeport Police Make Arrests, Seize 50 Pounds Of THC Products At Local Smoke Shops

Police seized THC products from smoke shops during compliance inspections, illustrating regulatory enforcement gaps that clinicians should monitor when counseling patients about legal product sourcing.

Read more →
#25

RYTHM (RYM) 2025 results: THC licensing growth but continued heavy losses – Stock Titan

RYTHM reported 2025 hemp-derived THC brand growth while maintaining financial losses, relevant to clinicians monitoring cannabis market consolidation and product availability trends.

Read more →
#25

Massachusetts Ballot Measure To Roll Back Marijuana Legalization Is Opposed By Most …

# Cannabis Clinician Summary A Massachusetts poll shows most residents oppose repealing marijuana legalization, which affects patient access to legal cannabis and clinical practice environments.

Read more →
#25

Massachusetts Poll: 63% Oppose Repealing Marijuana Legalization, Only 20% in Support – Reddit

# Massachusetts voters strongly oppose repealing marijuana legalization, with 63% opposing repeal versus 20% supporting it, reflecting public support for legal cannabis access.

Read more →
#25

N.S. RCMP crack down on cannabis dispensaries – YouTube

Nova Scotia RCMP enforcement action against illegal cannabis dispensaries highlights regulatory compliance issues clinicians should monitor regarding legal distribution channels and patient access pathways.

Read more →
#25

Retail cannabis market nearly finalized in the Commonwealth – WCYB

# Cannabis Clinician Summary Virginia is establishing a legal adult-use retail cannabis market, which may affect patient access, product quality standards, and clinical recommendations for healthcare providers.

Read more →
#25

Marijuana tax payouts dip in Michigan amid sales slump

# Cannabis Clinician Perspective Michigan’s declining marijuana tax revenues affect local government funding for public health and safety services that clinicians rely on for patient care coordination and community health infrastructure.

Read more →
#25

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

This article covers a medical cannabis delivery app expanding in the DMV region and Jamaica, relevant to clinicians seeking to understand emerging distribution methods for patient access.

Read more →
#25

Clarence Thomas Calls Out Attorney For Relying On ‘Illegality’ Of Marijuana In Gun Purchase Case

Supreme Court Justice Clarence Thomas questioned an attorney’s legal argument based on marijuana’s federal illegality in a gun purchase case, raising potential implications for cannabis policy interpretation.

Read more →
#25

‘Sober curious’ Gen Z adults drinking more than millennials were at same age, study finds

This article reports that Gen Z cannabis use increased from 31% to 49% by adulthood, providing clinicians with current epidemiological data on population-level substance use trends relevant to patient demographics and risk assessment.

Read more →
#25

High Schools Are Losing the Struggle to Block Pot—Even During Class – WSJ

# Summary for Cannabis Clinician This article examines increased marijuana use in high schools following legalization, highlighting accessibility and normalization challenges for schools attempting to prevent student use during school hours.

Read more →
#25

Mellow Fellow: Scientifically Powered Cannabinoids – Cannabis Now

Mellow Fellow is a pharmacist-founded company producing hemp-derived cannabinoid products with biodiverse formulations, relevant to clinicians evaluating cannabinoid product quality and pharmaceutical sourcing.

Read more →
#25

Cash, not rescheduling, is driving cannabis lending decisions – MJBizDaily

Cannabis lenders prioritize borrower cash flow over rescheduling prospects, affecting which cannabis businesses can access capital and maintain operations that clinicians may reference for patient recommendations.

Read more →
#25

Missouri Auditor Recommends Marijuana Tax Revenue Policy Change – Missourinet

# Summary for Cannabis Clinician Missouri’s generous marijuana retailer tax discount may affect product pricing and accessibility for patients, influencing clinical recommendations and patient affordability considerations.

Read more →
#25

Did you know this was happening in Oklahoma? – Instagram

# Summary Oklahoma law enforcement has dismantled thousands of illegal Chinese-operated marijuana cultivation sites, which impacts clinicians by affecting legal supply chains and cannabis quality/safety standards in the state.

Read more →
#25

Cannabis Stocks To Add to Your Watchlist – March 6th – Defense World

# Cannabis Stock Market Overview This article reviews publicly traded cannabis companies like Tilray, covering cultivation, distribution, and cannabinoid products relevant to clinicians prescribing cannabis therapeutically.

Read more →
#25

3 children rushed to hospital after teacher ‘gave them weed gummies to celebrate birthday …

# Summary for Cannabis Clinician This incident documents unintended pediatric cannabis exposure requiring emergency hospitalization, highlighting risks of inadequate product security and the critical need for childproof packaging standards.

Read more →
#25

Drug Arrests Surge 1,000, Driven by New Synthetic Narcotics

# Cannabis Clinician Summary This article reports increased drug arrests involving synthetic cannabis alongside other narcotics, which matters clinically because synthetic cannabinoids carry distinct pharmacological risks and toxicity profiles differing from natural cannabis.

Read more →
#25

New study reveals surprising benefit of GLP-1s that has nothing to do with weight loss

GLP-1 receptor agonists may reduce addiction to cannabis and other substances, offering cannabis clinicians a potential therapeutic tool for patients struggling with concurrent substance use disorders.

Read more →
#25

3 Children Rushed to Hospital After Teacher Allegedly Gave Them Weed Gummies

# Summary for Cannabis Clinician This case documents unintended pediatric THC exposure in an educational setting, highlighting the importance of child-resistant packaging, proper product storage, and clinical protocols for managing acute cannabinoid toxicity in minors.

Read more →
#25

A Promising Approach: Why young Indians are increasingly leaning into holistic wellness practices

This article examines cannabinoid interest among young Indian consumers within a holistic wellness framework, relevant to clinicians understanding emerging market trends and patient demographics.

Read more →
#25

Baxter County man facing 10 felony charges after 5 children test positive for THC | KTLO

# Summary for Cannabis Clinician A Baxter County man faces felony charges after five children tested positive for THC, highlighting legal and public health concerns regarding pediatric cannabis exposure incidents.

Read more →
#25

The hardest job in cannabis, and the most lucrative, is in cultivation – MJBizDaily

# Summary for Cannabis Clinician Cannabis cultivation roles command high salaries and industry demand, which affects product supply chain consistency and quality standards relevant to clinical recommendations.

Read more →
#25

Growing Pains – richmondmagazine.com

# Cannabis Business Profitability Survey This article examines 2024 national cannabis business profitability data showing only 27% are profitable, with significant racial disparities, which impacts clinicians’ understanding of market sustainability and access barriers.

Read more →
#25

2 local breweries part of lawsuit to keep THC drinks on store shelves

# Cannabis Clinician Summary Local breweries are in legal proceedings to maintain retail availability of hemp-derived THC beverages in Ohio, relevant to clinicians monitoring patient access to cannabis products.

Read more →
#25

GOP Congressman Running For Florida Governor Admits To Selling Marijuana Despite …

A GOP congressional candidate’s marijuana sales history conflicts with his legislative support for cannabis banking and research, raising questions about policy consistency relevant to clinical practice.

Read more →
#25

Judge’s ruling could force transparency in Menominee marijuana mess – MLive.com

A court ruling may compel disclosure of funding sources behind a Menominee ballot initiative restricting marijuana retailers, potentially affecting cannabis access and clinic operations in that jurisdiction.

Read more →
#25

Does marijuana help relieve or worsen your pain associated with fibromyalgia? – Reddit

This article discusses patient experiences with cannabis for fibromyalgia pain management, providing clinical insights into real-world efficacy and effectiveness from a patient perspective.

Read more →
#25

2 Cincinnati breweries sue State of Ohio over looming THC drink ban – WCPO

# Cannabis Clinician Summary Two Cincinnati breweries are challenging Ohio’s March 2026 THC beverage ban, raising questions about regulatory enforcement and product availability for patients and consumers.

Read more →
#25

Proof Launches California’s First 100% Legal Cannabis Pet Product

# Cannabis Pet Products and Clinical Relevance This article covers the launch of pharmaceutical-grade cannabis products for pets, relevant to clinicians because it demonstrates regulatory compliance standards and endocannabinoid system applications beyond human medicine.

Read more →
#25

Rare Cannabinoid Company Debuts CBC Mood Gummies – Prepared Foods

A cannabinoid company launched CBC-infused gummies targeting mood support, reflecting clinical interest in exploring cannabinoids beyond THC and CBD for therapeutic applications.

Read more →
#25

Your marijuana smoke in my nose? Arizona lawmakers say ‘no’

Arizona lawmakers enacted secondhand marijuana smoke restrictions, establishing legal boundaries for cannabis use that clinicians must consider when advising patients about consumption methods and locations.

Read more →
#25

Competitiveness fears weave through budget hearings – CommonWealth Beacon

# Cannabis Article Summary This article covers budget hearing discussions about cannabis research funding and its economic implications for Massachusetts, relevant to clinicians seeking research support and industry growth information.

Read more →
#25

The Best CBD for Joint Pain and Mobility in 2026 | stupidDOPE | Est. 2008

# Summary for Cannabis Clinician This article reviews CBD products for joint pain management, addressing the endocannabinoid system’s documented role in inflammation and stress regulation—key mechanisms relevant to orthopedic patient care.

Read more →
#25

Marijuana prices have been taking a nosedive. What comes next? – The Boston Globe

# Cannabis Market Oversaturation This article examines declining marijuana prices caused by market oversaturation, which impacts clinical cannabis availability, patient access costs, and dispensary sustainability that clinicians should monitor.

Read more →
#25

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors, Reinforcing Its …

EO Care appointed two board members to strengthen leadership in cannabinoid-based clinical care, relevant to clinicians seeking evidence-based cannabis treatment guidance.

Read more →
#25

Two Dakota nations sign cannabis compacts with state of Minnesota | MPR News

Minnesota Governor Tim Walz signed cannabis regulatory compacts with two tribal nations, establishing tribal authority over cannabis operations within their jurisdictions.

Read more →
#25

SC Republican Party State Chairman says ‘no’ to THC-infused drinks and other products

# Cannabis Clinician Summary South Carolina’s Republican Party chairman opposes THC-infused beverages while CBD and THC-A hemp remain legal, reflecting regulatory uncertainty clinicians must navigate when counseling patients on legal product availability.

Read more →
#25

Falling marijuana revenue and the fight over Michigan’s new cannabis tax

Michigan’s new 24% wholesale cannabis tax faces bipartisan repeal efforts, directly impacting product costs and patient access that clinicians must consider when recommending cannabis therapeutically.

Read more →
#25

D.C. proposes prorated cannabis licensing fees – Outlaw Report

D.C. is proposing prorated first-year licensing fees for new medical cannabis facilities, potentially reducing startup costs for clinicians seeking to establish or expand cannabis medical practice operations.

Read more →
#25

Virginia delays cannabis business registration | | mesabitribune.com

Virginia’s cannabis zoning restrictions require businesses to maintain 1,000-foot distances from schools, affecting clinician access to patient populations and practice location options.

Read more →
#25

Optimizing Post-Harvest Cannabis Processing for Sustained Efficiency, Quality, and Yield

This article addresses post-harvest processing optimization techniques including automation, facility design, and environmental controls—relevant to clinicians ensuring product quality and consistency for patient care.

Read more →
#25

Tilray Jumps 50% in Cannabis Rally After Trump Posts CBD Video – MSN

# Summary for Cannabis Clinician Tilray stock surged 50% following Trump’s promotion of CBD’s therapeutic potential for endocannabinoid system function and symptom management, signaling market sensitivity to political messaging about cannabis compounds.

Read more →
#25

Delaware retail weed sales fall far short of estimates – WHYY

# Delaware Retail Cannabis Sales Underperformance Delaware’s recreational marijuana retail sales are significantly underperforming projections, which may affect patient access, market sustainability, and revenue assumptions for cannabis policy development.

Read more →
#25

Growing to Wash: Why “Washers” Are Changing Cannabis – High Times Magazine

This article examines cannabis cultivation techniques focused on resin quality and hash production, relevant to clinicians assessing cannabinoid profiles and product potency for patient recommendations.

Read more →
#25

IRS Files First Response to Common Industry 280E Arguments | Harris Beach Murtha – JDSupra

# Cannabis Article Summary This article addresses IRS responses to Section 280E tax deductions in cannabis businesses, relevant to clinicians involved in cannabis operations facing federal tax compliance challenges.

Read more →
#25

Bipartisan Senate Bill Would Create Psychedelic-Focused VA Research Centers To Explore …

# Cannabis Clinician Summary A bipartisan Senate bill would establish VA research centers studying psychedelics, expanding federal research capacity on substances relevant to mental health treatment in veteran populations.

Read more →
#22

Cincinnati breweries file lawsuit over Ohio’s ban on intoxicating hemp – YouTube

# Cannabis Clinician Summary Cincinnati breweries are challenging Ohio’s prohibition on intoxicating hemp products, raising regulatory questions about cannabinoid classification and enforcement that affect cannabis practitioners’ understanding of legal product categories.

Read more →
#15

Arrests, Arraignments for Monday, March 2 – County 17

# Cannabis Clinician Summary This article documents criminal charges for THC product possession and impaired driving, providing case data relevant to understanding legal consequences and patient demographics in cannabis-related offenses.

Read more →
#15

Meet Pips: Grön’s Crispy, Crunchy, Cannabis-Infused Chocolate Pieces Arrive in New York

# Summary for Cannabis Clinician Grön’s Pips are 5mg THC chocolate pieces with adjustable cannabinoid ratios, offering precise microdosing options for patients requiring controlled, standardized cannabis dosing.

Read more →
#15

Commission questions fairness of security requirements at a Costa Mesa cannabis dispensary

A Costa Mesa cannabis dispensary sought to relax security requirements, raising potential regulatory and patient safety considerations for clinical cannabis practitioners.

Read more →
#15

Owner of Wichita dispensary indicted for trafficking marijuana from his stores – KWCH

# Legal/Regulatory Summary for Cannabis Clinicians A Wichita dispensary owner was indicted for marijuana distribution and firearms violations, highlighting regulatory enforcement risks and the legal distinction between licensed dispensaries and illegal trafficking.

Read more →
#15

Supreme Court questions denying gun rights to marijuana users in test of the 2nd Amendment

The Supreme Court is examining whether marijuana use alone justifies firearm restrictions, which impacts cannabis clinicians’ documentation practices and patient counseling regarding legal consequences.

Read more →
#15

Kinston police execute 34 search warrants in marijuana, THC investigation – WCTI

# Summary for Cannabis Clinician Kinston Police Department conducted a three-month investigation resulting in 34 search warrants related to illegal marijuana and THC product distribution in the area.

Read more →
#15

Forsyth Co. drug task force seizes over $1 million of THC vape pens | wfmynews2.com

# Summary for Cannabis Clinicians A Forsyth County drug task force seized over $1 million in THC vape products from an 18-year-old, highlighting illicit market distribution networks relevant to understanding youth exposure and product supply chains.

Read more →
#15

Marijuana Can Help With These Tips To Get A Spring Body – The Fresh Toast

This article discusses how cannabis compounds interact with the endocannabinoid system to regulate pain, relevant for clinicians assessing cannabinoid therapeutics and patient symptom management.

Read more →
#15

Trulieve Cannabis slashes 58 jobs at Florida call center – MJBizDaily

Trulieve, Florida’s largest cannabis retailer, laid off 58 call center employees, reflecting operational adjustments following earnings reports and regulatory challenges in the state’s marijuana market.

Read more →
#15

Giant Craft Brewer Falls to a Cannabis Conglomerate in a Fire Sale—Nearly 500 Jobs Disappear

# One-Sentence Summary Tilray’s acquisition of BrewDog’s operations represents major consolidation in cannabis-beverage markets, relevant to clinicians tracking industry shifts affecting cannabis product availability and formulations.

Read more →
#15

Connecticut Lawmakers Approve Bill To Expand Psychedelics Pilot Program In Anticipation …

Connecticut lawmakers expanded a psychedelics pilot program, potentially enabling clinical research into psychedelic-assisted therapies alongside cannabis therapeutics.

Read more →
#15

Police say package with meth and THC wax recovered inside Newberry Correctional Facility yard

# Cannabis Article Summary Police recovered THC wax and methamphetamine in a correctional facility, resulting in arrests of two adults and a juvenile—relevant to understanding substance trafficking patterns in institutional settings.

Read more →
#15

3 arrested following an attempt to smuggle drugs into Newberry Correctional Facility – WLUC

# Cannabis Clinician Summary Prison staff intercepted THC products smuggled into a correctional facility, illustrating supply chain security challenges relevant to regulated cannabis distribution and diversion prevention.

Read more →
#15

Tilray Brands, Inc. (TLRY) Strengthens U.S. Footprint With Long-Term Carlsberg Partnership

Tilray’s partnership with Carlsberg expands the company’s U.S. distribution capabilities, potentially increasing medical cannabis product accessibility through established beverage industry infrastructure.

Read more →
#15

Police raid Monett home near school, seize marijuana products, mushrooms and firearms

# Cannabis Clinician Summary A Monett, Missouri police raid recovered marijuana products and firearms from a residence near a school, resulting in drug and weapon charges relevant to cannabis legal compliance and community safety concerns.

Read more →
#15

NEW INFO: 26 vape shops, 8 homes raided in Kinston police crackdown – WITN

# Summary for Cannabis Clinician Kinston police conducted a three-month investigation resulting in raids on 26 vape shops and 8 residences targeting illegal marijuana and THC product sales, relevant to understanding unregulated product distribution and public health enforcement efforts.

Read more →
#15

Cannabis, beer, and wellness: Meet Tilray Brands, Ireland’s newest publican – The Currency

# Summary for Cannabis Clinician Tilray Brands acquired an Irish pub business for £33m, expanding into beverage retail alongside existing cannabis and pharmaceutical operations, demonstrating corporate diversification in cannabis-adjacent markets.

Read more →
#15

More than 500 pounds of marijuana seized by Arkansas State Police in Crawford County

Arkansas State Police seized 500 pounds of marijuana during a traffic stop, resulting in felony trafficking charges—relevant to clinicians monitoring legal cannabis market regulation and enforcement impact.

Read more →
#15

Man accused of running illegal marijuana operation gets $100K bond after AG misses hearing

A suspected large-scale illegal marijuana operator received a reduced bond due to prosecutorial oversight, raising concerns about enforcement of cannabis regulations.

Read more →
#15

Man arrested in Lenoir County with marijuana and pills found – WNCT

# Cannabis Article Summary A man was arrested in Lenoir County for marijuana possession with intent to distribute and illegal drug storage, charges relevant to clinicians assessing patient cannabis access legality and documentation requirements.

Read more →
#15

THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update

THC Therapeutics filed its annual 10-K report with regulatory updates relevant to investors and stakeholders monitoring the company’s financial performance and operational developments.

Read more →
#15

Trulieve’s 2025 Loss Narrows On Flat Sales Might Change The Case For Investing In …

This article analyzes Trulieve’s 2025 financial performance, examining how reduced losses despite stagnant sales may influence investment decisions in cannabis retail operations.

Read more →
#15

In Upper, not all public comment is against cannabis sales – Ocean City Sentinel

A Township Committee hearing on cannabis retail licensing in Petersburg revealed mixed public opinion on proposed sales, relevant to clinicians tracking regulatory developments affecting patient access.

Read more →
#15

Upper Township OKs cannabis sales despite public opposition – Ocean City Sentinel

Upper Township approved retail cannabis sales despite community opposition, affecting local access to cannabis products and regulatory compliance for clinicians treating patients in that area.

Read more →
#15

Pioneer Valley Trading Co. requests opportunity to grow marijuana in Southwick

A Massachusetts marijuana dispensary owner seeks cultivation licensing in Southwick, relevant to clinicians monitoring local supply chain development and product availability for patients.

Read more →
#15

Racine home drug bust; children test positive for drugs, 2 charged – FOX6 News Milwaukee

# Summary for Cannabis Clinician A home drug bust in Racine involved multiple substances including cannabis products, with children present testing positive for drugs, raising pediatric exposure and clinical management concerns.

Read more →
#15

Craft beer business struggling with rise of THC alternatives – YouTube

# Cannabis Clinician Summary The craft beer industry reports a 5% production decline, potentially reflecting consumer preference shifts toward THC products that may have clinical relevance for understanding patient substance use patterns.

Read more →
#15

Craft beer business struggling with rise of THC alternatives | wfmynews2.com

# Summary for Cannabis Clinician The craft beer industry is experiencing a 5% production decline, attributed to competition from THC products, indicating shifting consumer preferences toward cannabis alternatives.

Read more →
#15

ASX Cannabis Stocks in 2026: Is the risk worth the reward?

This article examines ASX-listed cannabis companies’ investment potential in 2026, featuring Cann Group as an early industry player with regulatory licensing experience relevant to clinical practitioners.

Read more →
#15

Accused $1.5B illegal marijuana operation ringleader freed from OK County jail on $100K bond

# Summary for Cannabis Clinicians A major illegal marijuana operation’s leader was released on bond, highlighting enforcement challenges in jurisdictions with legal cannabis markets and potential patient access implications.

Read more →
#15

Marijuana tax payouts dip in Michigan amid sales slump | WANE 15

# Summary for Cannabis Clinician Michigan’s marijuana tax revenues have decreased due to declining sales, which may affect cannabis research funding, patient program resources, and regulatory oversight capacity.

Read more →
#15

Cannabis Europa London 2026 Debuts New VIP Experience

# Cannabis Europa London 2026 Cannabis Europa London 2026 is returning for its third year and debuting a new VIP experience, relevant to clinicians interested in industry developments and clinical research updates.

Read more →
#15

Thumbs Up/Thumbs Down: March 6, 2026 | News, weather and sports from Alexandria, Minnesota

# Alexandria, Minnesota bans cannabis/THC use in city parks and public places, establishing local regulatory policy that clinicians should know when counseling patients about legal consumption locations.

Read more →
#15

12 Best Alcohol Stocks to Buy Right Now – Insider Monkey

This article lists top alcohol stocks but includes Tilray Brands, a cannabis company specializing in medical cannabis research and cultivation, relevant for clinicians tracking cannabis industry investments.

Read more →
#15

These Maine towns have the most cannabis businesses – Bangor Daily News

This article analyzes the geographic distribution of licensed cannabis cultivation, manufacturing, and retail operations across Maine municipalities, informing clinicians about local product availability and market accessibility for patients.

Read more →
#15

Supreme Court Skeptical of Marijuana User Gun Ban in Oral Arguments – Reddit

# Cannabis and Gun Ownership Legal Challenge This case examines whether federal law can prohibit firearm possession based solely on cannabis use, with implications for patient access and legal protections in medical cannabis practice.

Read more →
#15

Yunlin prosecutors indict Vietnamese nationals for marijuana smuggling – Focus Taiwan

# Cannabis Clinician Summary This article reports on drug enforcement against international marijuana trafficking, relevant to clinicians understanding legal/regulatory landscape affecting cannabis supply chains and patient access.

Read more →
#15

Piffton’s bold flavors shine atop a sometimes boring THC market – For The Win

# Summary for Cannabis Clinician This article discusses Piffton’s product differentiation through terpene profiling and flavor characteristics in the commercial THC market.

Read more →
#15

Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis

# Summary for Cannabis Clinician This article covers a major tobacco company’s acquisition of a cannabis producer, raising questions about industry consolidation and its potential impact on cannabis research and clinical practice standards.

Read more →
#15

Iowa man charged after DeKalb Co. traffic stop reveals over 9 pounds of cannabis – WIFR

# Cannabis Article Summary An Iowa man’s arrest for possessing over 9 pounds of cannabis during a traffic stop illustrates enforcement of state cannabis laws and trafficking-level quantities relevant to clinicians understanding legal boundaries.

Read more →
#15

Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health

# Summary for Cannabis Clinician Utah legislators approved a bill enabling clinical trials of psychedelics for veteran mental health treatment, expanding research opportunities in psychedelic-assisted therapy beyond traditional cannabis approaches.

Read more →
#15

ACCUSED MARIJUANA RINGLEADER RELEASED ON BOND The alleged leader of a $1.5 …

A defendant allegedly leading a $1.5 billion illegal marijuana operation was released on bond, which may inform clinicians about black market supply chain disruptions and product safety concerns.

Read more →
#15

Medical marijuana as someone working in healthcare industry : r/florida – Reddit

Healthcare workers with medical marijuana cards face workplace risks, making disclosure to employers or colleagues a significant concern despite legal authorization in Florida.

Read more →
#15

Suns forward Dillon Brooks arrested on suspicion of DUI – The New York Times

# Response This article covers a DUI arrest involving cannabis in Arizona, illustrating how impaired driving laws apply to marijuana use and the clinical relevance of assessing cannabis-related impairment.

Read more →
#15

Where Americans Spend their Trillions on Goods and How that Changed since 2015

# Cannabis Retail Sales Summary This article examines U.S. consumer spending trends on cannabis and other goods since 2015, showing 3.6% year-over-year growth, which helps clinicians understand market expansion and patient access patterns.

Read more →
#15

17-year-old charged with DUI after crashing into Knoxville home, leaving the scene, police say

# Summary for Cannabis Clinician This case illustrates the real-world consequences of cannabis use combined with alcohol in adolescents, highlighting the importance of screening for substance use in impaired driving incidents.

Read more →
#15

Three arrested after Holton search warrant – MSC News

# Summary for Cannabis Clinician Law enforcement arrested individuals for cannabis-related felony charges including THC possession and drug distribution communications, demonstrating ongoing criminal enforcement activity that may affect patient access to legal cannabis products.

Read more →
#15

Tilray Brands, Inc. (TLRY) Acquires BrewDog – Insider Monkey

# Summary for Cannabis Clinician Tilray Brands’ acquisition of BrewDog represents cannabis industry consolidation among major CPG firms, potentially affecting medical cannabis product availability and research capacity.

Read more →
#15

Substitute teacher accused of giving children cannabis gummies to ‘celebrate’ birthday – Cincinnati

A substitute teacher allegedly distributed cannabis gummies to students, raising concerns about accidental pediatric exposure risks and legal liability in educational settings.

Read more →
#15

Marijuana card : r/AskLE – Reddit

# Medical Cannabis and Firearms Licensing This covers how past medical cannabis card possession can disqualify applicants from concealed carry permits, which matters to clinicians because it affects patient privacy concerns and legal risks of recommendation documentation.

Read more →
#15

Excelsior Springs tables marijuana drive-thru vote, honors outgoing city manager

City council delayed a zoning decision on marijuana drive-thru dispensaries following youth prevention concerns, relevant to clinicians monitoring retail access patterns and public health policy impacts.

Read more →
#15

Inside Apotheca Cannabis Dispensary in Gastonia, NC – Gaston Gazette

# Summary for Cannabis Clinician This article features a dispensary visit showcasing edible cannabis products, relevant for clinicians counseling patients on available product types and patient education resources in North Carolina.

Read more →
#15

Primghar man arrested for OWI, marijuana | News – nwestiowa.com

# Cannabis Clinician Summary A man was arrested for operating while impaired with marijuana present in his vehicle, illustrating law enforcement detection methods and impaired driving prosecution relevant to cannabis clinical practice.

Read more →
#15

medical marijuana and pregnancy : r/eds – Reddit

This Reddit discussion addresses maternal cannabis use during pregnancy, a clinically relevant topic for cannabis clinicians managing pregnant patients with conditions like EDS.

Read more →
#15

From startup seedling to cannabis powerhouse, Verano has navigated the industry’s ups and downs

# Summary for Cannabis Clinicians This article covers Verano’s business growth in the cannabis industry amid widespread cultivation oversupply across states, relevant to clinicians understanding market dynamics affecting product availability and pricing.

Read more →
#15

Teen who killed 6 in THC crash got 65 years. Can Trump help him? – USA Today

This article covers a fatal vehicular accident involving THC impairment and its legal consequences, relevant to clinicians assessing cannabis-related driving impairment risks and public health implications.

Read more →
#15

LA’s $400 Million Cannabis Tax Gap: Last Week in Weed March 2–9, 2026

LA faces a $400 million cannabis tax revenue gap, which impacts funding for cannabis research, regulatory programs, and healthcare services clinicians depend on.

Read more →
#15

Forest Lake mayor to open city’s first cannabis dispensary | kare11.com

# Summary for Cannabis Clinician A Forest Lake mayor is opening the city’s first cannabis dispensary, expanding local retail access and potentially increasing patient availability in that region.

Read more →
#15

New medical Marijuana pick-up facility opening in Tyler – YouTube

A medical marijuana dispensary is opening in Tyler, Texas, expanding patient access to cannabis products in the region.

Read more →
#15

Forest Lake mayor to open city’s first cannabis dispensary – YouTube

# Summary for Cannabis Clinician A Forest Lake mayor is opening the city’s first licensed cannabis dispensary, expanding retail access in the region and potentially increasing patient access to regulated cannabis products.

Read more →
#15

The arrest of Phoenix Suns star Dillon Brooks in Scottsdale Friday has drawn new attention …

# Cannabis Clinician Summary This article covers Arizona’s DUI laws regarding marijuana impairment following a high-profile athlete’s arrest, relevant to clinicians assessing cannabis-related impairment and legal implications.

Read more →
#15

Beleaf cannabis dispensary opens in Medford after yearlong delay – Newsday

Beleaf cannabis dispensary opened in Medford after regulatory delays, reflecting Long Island’s expanding legal cannabis market and the approval challenges clinicians should understand when recommending patient access.

Read more →
#15

Citing ‘irreparable harm,’ TD Garden owner sues ‘The Boston Garden’ dispensary

# Summary for Cannabis Clinician A trademark dispute between a cannabis dispensary and an arena owner highlights legal risks cannabis operators face regarding business naming rights and regulatory compliance.

Read more →
#15

WSU students earn national honors at biomedical research conference

# Cannabis-Relevant Summary This article covers undergraduate biomedical research recognition and does not appear to address cannabis-related topics or clinical applications relevant to cannabis practitioners.

Read more →
#15

This Midwest state could be the next to legalize psilocybin – GreenState

# Summary for Cannabis Clinician This article covers Illinois’s potential legalization of psilocybin and relates to clinical cannabinoid research, relevant for clinicians tracking psychedelic and cannabis therapeutic developments.

Read more →
#15

Eastview Mall cannabis dispensary approved in Victor – Democrat and Chronicle

# Cannabis Clinician Summary A cannabis dispensary received approval to operate within a major shopping mall, expanding retail access points for patients seeking cannabis products and consultations.

Read more →
#15

Three charged for reported marijuana at playground | News | ncnewsonline.com

Three individuals were charged after police seized over half a pound of suspected marijuana from a vehicle at a playground, relevant to clinicians monitoring cannabis-related legal enforcement trends.

Read more →
#15

Zero Tolerance bust closes four dispensaries in Rosamond – Edwards AFB – Air Force

# Cannabis Clinician Summary Law enforcement closed four dispensaries in Rosamond near Edwards Air Force Base and seized approximately 541 pounds of marijuana in a zero-tolerance operation targeting illegal sales.

Read more →
#15

4 arrested after Louisville police seize 3D-printed guns, THC vapes | Crime Reports – WDRB

Louisville police arrested four individuals for illegally manufacturing and distributing THC vapes, illustrating regulatory enforcement challenges cannabis clinicians face regarding illicit product proliferation and patient safety.

Read more →
#15

The Best CBD Oil in the United States in 2026 | stupidDOPE | Est. 2008

This article reviews CBD oil products available in the United States, focusing on formulations with minimal additives for optimal endocannabinoid system interaction—relevant for clinicians recommending patient-appropriate cannabinoid products.

Read more →
#15

See how much people are spending on marijuana in Michigan and where at – mlive.com

# Cannabis Clinician Summary Michigan’s $3.17 billion recreational marijuana market data provides clinicians with regional consumption patterns and product volume information relevant to understanding patient access and market trends.

Read more →
#15

The ITA reports that Ju-Jitsu athlete Ilyas Aasli has been sanctioned with a two-year period …

# Cannabis and Sports Doping This article describes anti-doping sanctions for prohibited substances including cannabis, relevant to clinicians who advise athletes on drug testing policies and competitive eligibility.

Read more →
#15

More than 1.36 million pounds of marijuana flower was purchased in Michigan last year.

Michigan’s 1.36 million pounds of annual marijuana flower sales data provides clinicians with market volume information relevant to understanding cannabis availability and patient access patterns in the state.

Read more →
#15

The Future of Legal Magic Mushrooms is Complicated – Cannabis & Tech Today

This article discusses CBD’s interaction with the immune system and cannabis research related to COVID-19, relevant to clinicians considering immunological effects in patient treatment decisions.

Read more →
#15

Friend used me as a source of Marijuana for his clearance investigation – Reddit

This article discusses how a friend’s marijuana use disclosure during a security clearance investigation potentially implicated the source, highlighting legal and professional risks from association with cannabis users.

Read more →
#15

How a liquor store owner learned to love hemp THC beverages – MJBizDaily

This article documents a retail operator’s expansion into hemp-derived THC beverages, relevant to clinicians assessing patient access to legal cannabis alternatives and product diversity in regulated markets.

Read more →
#15

Rochester smoke shop faces scrutiny after cannabis seizure, remains open – WHEC.com

# Summary for Cannabis Clinician A Rochester smoke shop operated despite authorities seizing illicit cannabis, highlighting regulatory enforcement gaps that may affect patient access to legal, clinically-appropriate cannabis products.

Read more →
#15

Colorado Weed Prices Reach a Sad New Low

# Cannabis Price Information Relevant to Clinicians Colorado’s retail marijuana prices have declined to $608 per pound, the lowest recorded level, which may affect patient access costs and treatment affordability.

Read more →
#15

Swarthmore put limits on stores like smoke shops| Inquirer Greater Media

Swarthmore implemented zoning restrictions limiting smoke shops and marijuana dispensaries, affecting cannabis business licensing and patient access to legal retail options in the municipality.

Read more →
#15

LMPD seizes 16 Glock switches, 3D printed guns, 120 THC vape pens during search

# Cannabis Clinician Summary Louisville police seized 120 THC vape pens during a March 6 search, highlighting illicit cannabis product distribution and unregulated potency concerns relevant to clinical practice.

Read more →
#15

The Cannabis Consumer Community Is Just As Bipartisan As The General Population …

# Cannabis Consumer Politics This article demonstrates that cannabis users’ political affiliations mirror the general population, which may inform clinicians’ understanding of patient demographics and help avoid assumptions about their patients’ political beliefs.

Read more →
#15

possession of narcotic drugs for sale, possession of marijuana for sale, and manufacturing drugs

# Cannabis Clinician Summary This article covers legal consequences of large-scale cannabis possession and distribution, relevant to clinicians who must understand federal/state law distinctions and patient legal risks.

Read more →
#12

LaGrange police arrest suspected drug trafficker, find dozens of pounds of marijuana

# Cannabis Clinician Summary Law enforcement arrested a suspected marijuana trafficker with firearm charges, relevant to clinicians documenting patient substance use histories and understanding illicit supply chain disruptions.

Read more →
#12

Ongoing marijuana odor issue : r/Apartmentliving – Reddit

This article documents a shared-housing complaint about secondhand marijuana smoke exposure in a ventilated apartment building, relevant to clinicians assessing environmental exposure and odor-related health concerns.

Read more →
#12

SWLA Arrest Report – March 10, 2026

# Cannabis Clinician Relevance This arrest report documents a marijuana possession charge among other offenses, providing data on cannabis-related legal outcomes in Southwest Louisiana that informs clinical understanding of patient legal risks and demographics.

Read more →
#12

Inside Portland’s cannabis packaging recycling facility — Oregon’s most extensive program

# Cannabis Packaging Recycling in Oregon A Portland facility recycles cannabis containers statewide, converting them into nursery pots, addressing environmental waste management relevant to cannabis industry sustainability.

Read more →
#8

New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

A new cannabis dispensary called Root 22 has opened on Route 22 in Somerville, NJ, expanding local patient access to cannabis products.

Read more →
#5

Middle Island man found with over 150 pounds of marijuana in minivan – News12

# Cannabis Clinician Summary Law enforcement seized over 150 pounds of cannabis from a Middle Island resident, highlighting illicit distribution activity relevant to understanding non-medical market supply chains.

Read more →
#5

Tenet Healthcare (THC) CFO logs RSU award, vesting and tax share disposals

# Response This article does not cover cannabis; it reports on Tenet Healthcare’s CFO stock transactions and is irrelevant to cannabis clinicians.

Read more →
#5

Tenet Healthcare COO reports equity grants and tax trades | THC SEC Filing – Stock Titan

# Cannabis Clinician Summary This SEC filing documents Tenet Healthcare executive compensation activity unrelated to cannabis; it has no relevance to cannabis clinicians or the cannabis industry.

Read more →
#5

Psilocybin could combat post-treatment Lyme disease, new study finds – leafie

This article discusses research on psilocybin’s potential therapeutic applications for post-treatment Lyme disease symptoms, relevant to clinicians exploring psychedelic treatments for complex chronic conditions.

Read more →
#5

Buy Recreational Marijuana Products in Columbus, OH | Bloom

# Cannabis Clinician Summary This webpage describes a recreational marijuana retailer in Columbus, Ohio that requires age verification (21+ for adult use), relevant for clinicians tracking legal cannabis access and patient demographics.

Read more →
#5

Tenet Healthcare (THC) Valuation Check After Strong Recent Share Price Momentum

This article discusses Tenet Healthcare’s stock valuation and recent price movements, which is unrelated to cannabis clinical practice or medicine.

Read more →
#5

Police: Man charged after feeding parakeet marijuana, beer in Westmoreland County

# Cannabis article summary for clinician This article reports animal cruelty charges involving cannabis and alcohol administration to a bird, illustrating potential legal consequences of cannabis misuse outside medical contexts.

Read more →
#5

Bemidji Chamber Ambassadors welcome Coconut Cannabis

# Summary for Cannabis Clinician A cannabis retail establishment opened in Bemidji with Chamber of Commerce recognition, indicating regulatory approval and community acceptance of legal cannabis commerce in that market.

Read more →
#5

New Iberia traffic stop uncovers marijuana, THC products – KLFY.com

# Cannabis News Summary A traffic stop in New Iberia resulted in arrest for illegal marijuana and THC product possession, illustrating enforcement of cannabis prohibition laws relevant to clinician awareness of legal penalties patients may face.

Read more →
#5

Gainesville man arrested for selling marijuana, methamphetamines, and pills

A cannabis clinician should note this case documents law enforcement arrest for illegal drug distribution, distinguishing illicit market activity from regulated medical cannabis practice.

Read more →
#5

BRPD arrest man on various drug and gun charges following the execution of a search warrant

# Cannabis Clinician Summary Law enforcement arrested an individual with marijuana, cash, and stolen firearms following a search warrant execution, relevant to clinicians assessing patient legal histories and safety risks.

Read more →
#5

P640-M worth of marijuana seized at Manila Port, 1 arrested | GMA News Online

# One Sentence Summary A significant marijuana seizure at Manila’s port highlights drug trafficking enforcement and may inform clinicians about illicit supply chain disruptions affecting patient access to cannabis products.

Read more →
#5

SWLA Arrest Report – March 7, 2026

# Cannabis Clinician Summary This arrest report documents charges against an individual including synthetic marijuana possession, relevant to clinicians assessing patient substance use history and legal/clinical risks.

Read more →
#5

Police Blotter – The Spectator

# Summary for Cannabis Clinician Local police responded to a marijuana report among other incidents, documenting community law enforcement activities relevant to cannabis regulation monitoring.

Read more →
#5

How Investors May Respond To Tenet Healthcare (THC) Amid Jobs Report Jitters And …

# Response This article discusses Tenet Healthcare’s stock performance following weak employment data—irrelevant to cannabis clinical practice as it covers general healthcare investment trends, not cannabis medicine or policy.

Read more →
#5

Executive Marijuana Supply Chain Jobs in Ohio (NOW HIRING) – ZipRecruiter

# Summary for Cannabis Clinician This article lists executive-level cannabis supply chain positions in Ohio, relevant to clinicians who need to understand industry operations affecting product sourcing and patient access.

Read more →
#5

John F. Kennedy Jr. Smoked Marijuana ‘Every Single Day’ Starting at Age 15, Pal Claims in Book

# Cannabis Use Summary This article reports claims about a historical figure’s adolescent marijuana use patterns, potentially relevant to clinicians studying long-term cannabis effects and age of initiation correlates.

Read more →
#5

2 adults arrested after IMPD shuts down underage party on Indy’s west side – WTHR

# Cannabis Article Summary IMPD shut down an underage party with marijuana and alcohol present, resulting in two adult arrests—relevant to clinicians treating adolescent substance use.

Read more →
#5

Former Monroe County commissioner Mark Brant cited for marijuana – Facebook

# Cannabis Clinician Summary Former elected official cited for marijuana violations; relevant to clinicians for understanding local enforcement patterns and regulatory compliance in their jurisdiction.

Read more →
#5

Texas man flying to London had 75 pounds of pot in luggage at MIA, police say – NBC 6

A Texas man was arrested at Miami airport after TSA discovered 75 pounds of marijuana in his luggage before boarding a London flight, highlighting enforcement of cannabis trafficking laws at airports.

Read more →
#5

Notice to proceed for courthouse work received from THC | Refugio County Press

This article covers a courthouse restoration project update in Refugio County and is not relevant to cannabis clinicians.

Read more →
#5

H-E-B unveils inaugural mini market in West Texas school – MySA

# Summary for Cannabis Clinician This article covers H-E-B’s new mini market in a West Texas school and mentions a local hemp product retailer, relevant to understanding retail cannabis accessibility and product availability in Texas.

Read more →
#5

N.Y. cannabis grower to be featured in reality series – Spectrum News

# Summary for Cannabis Clinician This article covers a New York licensed cannabis grower being featured in a reality television series, relevant to clinicians tracking cannabis industry developments and regulatory frameworks.

Read more →
#5

#paulmccartney #marijuana #thebeatles – Instagram

This Instagram post uses hashtags linking Paul McCartney, marijuana, and The Beatles, but contains no substantive clinical, research, or medical information relevant to cannabis clinical practice.

Read more →
#5

Swansea cannabis shop CEO says no property auction. ‘I had no idea.’

# Summary for Cannabis Clinician A Swansea cannabis retailer’s CEO clarified misconceptions about property auction rumors, confirming business continuity—relevant for tracking operational stability of local cannabis dispensaries.

Read more →
#5

Min Woo Lee’s puppy got high at TPC Sawgrass – Golfweek

# Cannabis Clinician Summary This article documents unintentional THC exposure in a dog, illustrating accidental ingestion risks in households with cannabis products and relevant toxicology considerations.

Read more →
#0

Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest

This study examines the relationship between cannabis use and brain aging markers using large population datasets, providing evidence-based data clinicians can reference when counseling patients about potential neurological effects.

Read more →
#0

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

# Cannabis Article Summary This propensity-score-matched study compares cannabis use disorder outcomes against other substance use disorders using TriNetX data, helping clinicians understand how cannabis disorder differs clinically and prognostically from other addictive substances.

Read more →
#0

Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC), Stock a … – StreetInsider

# Response This article does not cover cannabis-related topics. It discusses Tenet Healthcare (THC ticker symbol), a hospital operator, and an analyst rating—not cannabis medicine or clinician practice.

Read more →
#0

Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking. | High Times

Hemp-derived THC beverages are rapidly entering mainstream markets, creating competition concerns for alcohol industries and presenting clinicians with new patient consumption methods to monitor.

Read more →
#0

Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference – Stock Titan

This article announces Tenet Healthcare’s participation in a major healthcare conference; irrelevant to cannabis clinicians as Tenet is a hospital operator unrelated to cannabis medicine or industry.

Read more →
#0

Girl Scout Cookies Strain: Effects, THC Content & Review in 2026 – Herb.co

This article reviews the Girl Scout Cookies cannabis strain, including its THC content and effects, with research on cannabis’s acute impact on intimate experiences.

Read more →
#0

High Tide joins U.S. National Compassionate Care Council | HITI Stock News

High Tide joined the U.S. National Compassionate Care Council to advance medical cannabis policy modernization and patient access to cannabinoid therapies, directly impacting clinical practice standards.

Read more →
#0

A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

# Summary This article presents a digital therapeutic framework to standardize medical cannabis treatment using precision medicine principles, enabling clinicians to deliver personalized, evidence-based cannabinoid care.

Read more →
#0

Wisconsin Governor Pushes To Stop Federal Hemp THC Ban, Saying Lack Of … – Marijuana Moment

# Summary for Cannabis Clinician Wisconsin’s governor opposes federal hemp THC restrictions, affecting cannabinoid product availability and regulatory standards that clinicians must navigate when recommending hemp-derived treatments.

Read more →
#0

Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML

# Cannabis Study Summary for Clinicians This study examines whether lifetime cannabis use affects cognitive decline or dementia risk, providing clinical evidence relevant to patient counseling about long-term neurological outcomes.

Read more →
#0

Cannabis edibles | | wvnews.com

# Summary for Cannabis Clinician West Virginia expanded its medical cannabis program to permit licensed dispensaries, which may increase patient access to regulated cannabis products and standardized dosing information.

Read more →
#0

D.C. licensed medical cannabis grower closed by law enforcement – Outlaw Report

# Summary for Cannabis Clinicians A licensed medical cannabis cultivation facility in Washington, D.C. was shut down by law enforcement, potentially affecting local patient access to regulated medical cannabis products.

Read more →
#0

Branch County sees decline in marijuana tax revenue for 2025 | WTVB

# Cannabis Article Summary Branch County local governments are experiencing reduced marijuana tax revenue distributions in 2025, affecting public health funding available for cannabis-related clinical services and education.

Read more →
#0

Nebraska U.S. Senate race filled with alleged ‘plants,’ campaigns say

This article discusses cannabis legalization politics in Nebraska’s Senate race, relevant to clinicians tracking regulatory and legal landscape changes affecting patient access and medical cannabis programs.

Read more →

Digest-Level Clinical Commentary

Dr. Caplan’s Take
# Clinical Reflection Looking across this digest, I’m struck by the disconnect between emerging preclinical evidence supporting cannabinoid therapeutics for metabolic and pain conditions and the regulatory fragmentation that prevents coherent clinical implementation. The proliferation of state-level regulatory frameworks, inconsistent THC potency standards, and ongoing FDA enforcement actions suggest we’re witnessing the maturation of a consumer cannabis market outpacing our ability to establish standardized dosing protocols and quality assurance for medical applications. As clinicians, we need to advocate forcefully for federal rescheduling and funding for rigorous human trials, because the current evidence base of small studies and isolated biomarkers cannot yet support the clinical claims emerging in popular discourse.
Clinical Perspective

# Clinical Perspective on Cannabis Research and Regulatory Trends The digest reflects a maturing cannabis landscape characterized by increasing scientific investigation into specific cannabinoid mechanisms, particularly CBD and CBG for metabolic and pain conditions, alongside evolving regulatory approaches to product potency and formulation standards. Concurrent regulatory developments across multiple jurisdictions suggest growing attention to standardization of dosing and delivery methods, which aligns with the clinical need for reproducible, evidence-based cannabinoid therapeutics. The emerging research on cannabinoid efficacy for conditions such as fatty liver disease and myofascial pain, coupled with regulatory frameworks addressing potency limitations, indicates a gradual shift toward treating cannabis as a pharmacologically distinct intervention rather than a commodity product.

Regulatory PolicyMedical ResearchState LegislationProduct InnovationCannabinoid Science

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →